English
Português
IN SILICO · UEFS · SINCE 2007
From molecular target to drug candidate
Virtual screening, docking, molecular dynamics and AI to discover molecules against tuberculosis, leishmaniasis and other neglected diseases.
19years of research
12publications
16projects
24team members
Research lines
The laboratory’s four lines of work.
CADD
Computer-aided drug design.
View projects →Molecular dynamics
We simulate molecular motion and interactions in a computational environment.
View projects →Molecular modeling
We use computational tools to represent and analyze molecules at the atomic level.
View projects →In vitro evaluation
We evaluate the action of molecules in biological models to screen for pharmacological activity.
View projects →Team
Meet the people behind LMM.
Recent publications
Click an article to open it on the journal’s website.
2026Schinus terebinthifolia fruit as source of acetylcholinesterase inhibitors: unveiling its bioactive compounds through HPLC-ESI-MSn and in silico analysisOpen article →
2026Characterization of molecular targets as a strategy for the development of new anthelmintics: a literature reviewOpen article →
2026Bioprospection of photoprotective natural compounds from Persea fulva: a good source of acylated glycosylated flavonoids for application in new sunscreen formulasOpen article →
2025Estudos in silico para a identificação de potenciais inibidores frente ao CCR2 associado ao processo inflamatório causado pelo vírus ChikungunyaOpen article →
2025In vitro and in silico studies of GST-inhibitory and larvicidal activities of alkaloids against Rhipicephalus microplusOpen article →
2024Priorização in silico de moléculas com ação sobre M. tuberculosis pantotenato sintetaseOpen article →